Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Cash (2016 - 2025)

China Pharma Holdings filings provide 16 years of Change in Cash readings, the most recent being $77487.0 for Q4 2025.

  • On a quarterly basis, Change in Cash rose 184.4% to $77487.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$281767.0, a 64.64% increase, with the full-year FY2025 number at -$281767.0, up 64.64% from a year prior.
  • Change in Cash hit $77487.0 in Q4 2025 for China Pharma Holdings, up from -$357407.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $4.4 million in Q4 2021 to a low of -$1.5 million in Q2 2022.
  • Median Change in Cash over the past 5 years was -$129104.0 (2022), compared with a mean of -$30627.1.
  • Biggest five-year swings in Change in Cash: soared 620.12% in 2021 and later plummeted 1631.12% in 2025.
  • China Pharma Holdings' Change in Cash stood at $4.4 million in 2021, then tumbled by 101.28% to -$56327.0 in 2022, then skyrocketed by 195.81% to $53967.0 in 2023, then tumbled by 270.13% to -$91812.0 in 2024, then soared by 184.4% to $77487.0 in 2025.
  • The last three reported values for Change in Cash were $77487.0 (Q4 2025), -$357407.0 (Q3 2025), and $212344.0 (Q2 2025) per Business Quant data.